{"entity":{"type":"insider","cik":"0001920574","url":"/insider/0001920574","json_url":"/insider/0001920574.json","name":"OrbiMed Capital GP IX LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":2,"first":"2025-09-02","last":"2026-08-11","span_basis":"filed_date"},"name_variants":[{"name":"OrbiMed Capital GP IX LLC","source":"filing","n_filings":2,"first_seen":"2025-09-02","last_seen":"2026-08-11"}],"transactions":[{"id":9211160,"accession":"0000947871-26-000782","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-26-000782","line_url":"/filing/0000947871-26-000782","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Braveheart Bio, Inc.","issuer_ticker":"BRVE","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP IX LLC; OrbiMed Genesis GP LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1940000.0,"shares_display":"1,940,000","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":34920000.0,"total_display":"34,920,000.00","total_whole":"34,920,000","shares_owned_after":11901826.0,"shares_owned_after_display":"11,901,826","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-07","filed_date":"2026-08-11","scope":"insider","n_lines":2},{"id":4574627,"accession":"0000947871-25-000840","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-25-000840","line_url":"/filing/0000947871-25-000840","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Shattuck Labs, Inc.","issuer_ticker":"STTK","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Genesis GP LLC; OrbiMed Capital GP IX LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Genesis GP LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6306127.0,"shares_display":"6,306,127","price_per_share":0.8677,"price_display":"0.87","price_state":"stated","total_value":5471826.3979,"total_display":"5,471,826.40","total_whole":"5,471,826","shares_owned_after":5255106.0,"shares_owned_after_display":"5,255,106","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-25","filed_date":"2025-09-02","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0002131524","name":"Braveheart Bio, Inc.","url":"/issuer/0002131524","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2026-08-11","last_seen":"2026-08-11"},{"type":"issuer","type_label":"ISSUER","cik":"0001680367","name":"Shattuck Labs, Inc.","url":"/issuer/0001680367","role":"Director","n_filings":1,"first_seen":"2025-09-02","last_seen":"2025-09-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001920574","retrieved_at":"2026-08-23T23:46:29+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}